A matched cohort comparison of endoscopic resection, chemoradiation and esophagectomy in the treatment of early-stage esophageal squamous cell carcinoma - 07/03/23
Abstract |
Background |
The efficacy of endoscopic resection in early-stage esophageal squamous cell carcinoma has not been defined.
Methods |
We queried the National Cancer Database to identify patients presenting with cT1N0M0 esophageal squamous cell cancer between 2004 and 2017. Transitive match methods were used to 1:1:1 propensity match patients undergoing endoscopic resection to patients undergoing esophagectomy and those undergoing definitive chemoradiotherapy. Kaplan Meier method was used to compare 5-year overall survival profiles for matched cohorts.
Results |
301 patients (19%) underwent endoscopic resection; 497 (32%) esophagectomy; 767 (49%) chemoradiation. On comparison of matched cohorts, patients undergoing chemoradiation demonstrated lower rates of survival than those undergoing esophagectomy (32% vs. 59%, p < 0.0001) while those undergoing endoscopic resection demonstrated rates comparable to patients undergoing esophagectomy (53% vs. 59%, p = 0.77).
Conclusions |
For cT1N0M0 esophageal squamous cell cancer, endoscopic resection is associated with rates of survival similar to those following esophagectomy and better than those following definitive chemoradiation.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Endoscopic resection for cT1N0M0 squamous cell carcinoma had comparable survival rates to esophagectomy. |
• | Esophagectomy and endoscopic resection had a risk-adjusted absolute survival advantage of 27% and 21% relative to CRT. |
• | Endoscopic resection was associated with accelerated rates of post-operative recovery but higher rates of R1 resection. |
Keywords : Esophagectomy, Endoscopic resection, Squamous cell, Early
Plan
| ☆ | This work will be featured in an oral presentation at the Midwest Surgical Association annual meeting, held in Mackinac Island, Michigan from August 7–9, 2022. |
Vol 225 - N° 3
P. 508-513 - mars 2023 Retour au numéro
Article précédent
- Out of sight, out of mind? The impact on trauma patient opioid use when the medicine administration schedule is not displayed
- Hordur M. Kolbeinsson, Jason Aubrey, Matthew M. Lypka, Steffen Pounders, Laura A. Krech, Chelsea S. Fisk, Alistair J. Chapman, Charles J. Gibson
- Use of a national registry to define a composite quality metric for rectal cancer
- Celsa M. Tonelli, Sujay Kulshrestha, Marc Singer, Timothy M. Pawlik, Fred A. Luchette, Zaid M. Abdelsattar, Marshall S. Baker
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?